Podcast: Russia expert discusses fears of Putin's 'madness' over Ukraine

Mar 14, 2022

4 min

Dr Elisabeth Schimpfössl


  • Speculation that isolation caused by Covid-19 pandemic could have affected his state of mind
  • Closest advisers said to fear for their lives if they speak out against him
  • Potential scenarios considered include a ‘heart attack-style’ assassination of dictator by senior military and secret services.


Two years spent isolating during the coronavirus pandemic have led to a debate that Russian President Vladimir Putin has gone ‘bonkers’, resulting in the invasion of Ukraine.


There is now even speculation that only a “heart attack-style” assassination of the dictator by his senior military and secret services could prevent Putin from seeking to expand his borders even further.


These themes were discussed by Dr Elisabeth Schimpfössl, a senior lecturer in sociology and policy at Aston University, and author of the award-winning book Rich Russians: From Oligarchs to Bourgeoisie.


Dr Schimpfössl, speaking about the ongoing Russian invasion of Ukraine as part of the 'Society matters' podcast series, presented by journalist Steve Dyson, explained there were two reasons why Putin had decided to invade its neighbour.


She considered two potential reasons behind the invasion: “The first is he has always had ambitions to incorporate eastern Ukraine and, particularly, keep NATO at bay and not have it anywhere so close to Russia’s own borders. The second thought is whether Putin might have simply lost it, in a clinical sense.”


Dr Schimpfössl said Putin had been “extremely isolated” during the pandemic, with very few people allowed to see him in his “bunker”.


She added: “It might well be, as bizarre as it sounds and unimaginable as it might be, that he is losing it and courting advice from people who have such fear of him that they would say what he wanted to hear.”


While such madness is currently pure speculation, Dr Schimpfössl explained how people close to him would potentially “fear for their lives” if they contradicted him or alerted him to what a “crazy idea” war was. She said Russian Foreign Minister Sergey Lavrov, whose daughter lives in New York, had wanted to retire “years ago” but Putin would not let him.


And she mentioned claims that the former head of Russia’s foreign secret service died from an apparent heart attack after he “pretty much messed up” the poisoning of double agent Sergei Skripal in Salisbury in 2018.


She said: “It’s pretty obvious that similar fears were deep in the bones of all the closest entourage of Putin. They all know pretty well how the system works.”


Dr Schimpfössl described reports on how opposition activists and investigative journalists “suddenly, suspiciously, jump off their balcony to their death. And they threaten people that if they don’t jump then their family will suffer”.


She suggested that Russia’s billionaire oligarchs could have taken measures if they had seen what was coming. However, the European Union had now added oligarchs onto the sanctions list for the first time after being deeming them “Putin’s cronies” instead of business leaders.


Dr Schimpfössl said: “Until Friday, Putin’s plan was to succeed within maybe a week and sanctions would have become effective in weeks, or months from now. Now things have changed and the EU sanctions have gone a big step further on.”


She said it will be a “catastrophe” for Russia’s oligarchs now they are subject to sanctions. The only thing that could “save their skin”, she added, is if they create an image of being “anti-war, anti-Putin”. But would this help stop Putin?


“Not if he’s completely gone bonkers, then nothing will stop him,” Dr Schimpfössl again speculated. “It makes him extremely dangerous in terms of his announcement of using nuclear weapons. It would be the maddest possible thing to do, but there is no guarantee anymore.”


The only thing that could stop him, she hypothesised, was if Putin suffered the similar fate of a “sudden heart attack” following a “silent coup” by Russia’s top military and secret services, although it is pure conjecture that any such actions are being planned.


Opinion polls in Russia suggest that only 40 per cent of the population support the action against Ukraine, compared to 80 per cent over the annexation of Crimea in 2014.


Dr Schimpfössl said she hoped negotiations between Russia and Ukraine would lead to an agreement, but added: “We know from history when an aggressor sees itself being on the losing end, or things not go according to plan, they often lash out at the very last moment. Any escalation of the conflict could easily and very quickly get very cruel and barbaric.”


Episode 1 in series 3 of the ‘Society matters’ podcast and all previous episodes can be found HERE.

Connect with:
Dr Elisabeth Schimpfössl

Dr Elisabeth Schimpfössl

Senior Lecturer

Dr Schimpfössl's research interests are the sociology of elites as well as power and social inequality.

PhilanthropySocial InequalitySociologyElitesRussia

You might also like...

Check out some other posts from Aston University

2 min

How mitochondria shape brain health from childhood to old age

From the first spark of neural development to the challenges of ageing, Dr Lissette Sánchez Aranguren is uncovering how the cell’s powerhouses — mitochondria — hold the key to a healthy brain across the human lifespan. Her pioneering research at Aston University explores how these microscopic energy generators safeguard the brain’s communication network and how their dysfunction may underlie conditions such as dementia, stroke, and neurodevelopmental disorders. Mapping the brain’s energy defence system Dr Sánchez Aranguren’s work focuses on the partnership between brain cells and the blood vessels that nourish them — a relationship maintained by the blood–brain barrier. When mitochondria fail, that protective interface can weaken, allowing harmful molecules to penetrate and trigger inflammation or cell loss. Her team’s studies show that mitochondrial malfunction disrupts the dialogue between neurons and vascular cells, an imbalance seen both in the developing and ageing brain. To counter this, she and her collaborators have engineered a mitochondria-targeted liposome, a nanoscale “bubble” that delivers restorative molecules directly where they are needed most. By re-balancing cellular energy and communication, this innovation could one day reduce brain injury or slow neurodegenerative decline. From heart cells to the human mind Originally trained in cardiovascular science, Dr Sánchez Aranguren became fascinated by how mitochondria regulate energy and stress in blood-vessel cells — insights that ultimately led her toward neuroscience. View her profile here “Mitochondria do much more than produce energy. They send signals that determine how cells communicate and survive.” That realisation inspired her to trace mitochondrial signalling across the continuum of life — linking early brain development to later-life vulnerability. Her research now bridges traditionally separate fields of developmental biology, vascular physiology, and ageing neuroscience, helping identify shared molecular pathways that influence lifelong brain resilience. Global collaboration for a healthier brain Her work thrives on multidisciplinary and international partnerships. At  Aston, she collaborates with scientists from Coventry University, Queen’s University Belfast, and the University of Lincoln, alongside research partners in the Netherlands, Italy, Malaysia, and China. Together they integrate chemistry, biology, and computational modelling to understand mitochondrial function from molecule to organism — and translate discoveries into practical therapies. Towards mitochondria-targeted brain therapies The next frontier is refining these mitochondria-targeted nanocarriers to enhance precision and efficacy in preclinical models, while exploring how mitochondrial signals shape the brain’s vascular and neural architecture from infancy through adulthood. Dr Sánchez Aranguren envisions a future where protecting mitochondrial health becomes central to preventing brain disease, shifting medicine from managing symptoms to preserving the brain’s natural defence and repair systems. “If we can protect the cell’s own energy engines,” she says, “we can give the brain its best chance to stay healthy for life.”

2 min

From circular supply chains to global sustainability leadership: How Dr Luciano Batista is shaping the future of the circular economy

When it comes to transforming how organisations produce, consume, and reuse resources, Dr Luciano Batista, professor of operations management at Aston University, is a global pioneer. His research sits at the crossroads of innovation, digital transformation, and sustainability, tackling one of humanity’s most pressing challenges: our overconsumption of the planet’s resources. Reimagining the economy around renewal Dr Batista’s work focuses on circular supply chains —a model he helped establish at a time when 'closed-loop' systems dominated sustainability thinking. His early research laid the foundation for how businesses could move beyond recycling and linear take-make-dispose models, instead designing systems that reuse, restore, and regenerate.  View his profile here From theoretical frameworks to real-world applications, his studies—such as comparative analyses of circular systems implemented by Tetra Pak in China and Brazil—demonstrate the measurable economic and environmental benefits of circularity in action. His 2022 Emerald Literati Award-winning paper introduced a methodology for mapping sustainable alternatives in food supply chains, earning international recognition for its real-world impact. A global voice for industrial symbiosis and circular innovation The influence of Dr Batista’s work reaches far beyond academia. He has advised the European Commission’s Circular Cities and Regions Initiative (CCRI) and contributed insights to policymakers through the UK All-Party Parliamentary Manufacturing Group. His expertise continues to inform national and regional strategies for sustainable production and industrial symbiosis —where one company’s waste becomes another’s resource. Today, he extends that impact globally as a visiting professor at the Massachusetts Institute of Technology (MIT), conducting research at the MIT Center for Transportation & Logistics on circular supply chain innovations, supported by Aston University’s study-leave programme. He also mentors future leaders in sustainability as part of Cambridge University’s Institute for Sustainability Leadership (CISL). Driving the next wave of sustainable transformation Looking ahead, Dr Batista is spearheading collaborations through Aston’s Centre for Circular Economy & Advanced Sustainability (CEAS), working with the Energy & Bioproducts Research Institute (EBRI) and West Midlands Combined Authority (WMCA) on projects developing biochar-based clean energy systems for urban districts. He is also advancing the social dimension of the circular economy—ensuring that the move toward sustainable production is inclusive and equitable. His Symposium on the Socially Inclusive Circular Economy, held at the 2025 Academy of Management Conference, has sparked new international research partnerships with Monash University (Australia) and the Vienna University of Economics and Business. A vision for a regenerative future At the heart of Dr Batista’s work is a simple but urgent truth: humanity is consuming resources at a rate our planet cannot sustain. Through his research and global collaborations, he is helping organisations, policymakers, and communities move toward a future where growth and sustainability coexist. “The transition to a circular economy is not optional—it is essential,” says Dr Batista. “Our goal must be to redesign systems that allow people, businesses, and ecosystems to thrive together.”

2 min

Aston University’s Ian Maidment helps develop training for pharmacy staff supporting those with long COVID

The e-learning resource, Supporting people living with long COVID, was developed by the Centre for Pharmacy Postgraduate Education (CPPE) It is designed to help community pharmacy teams build their skills, knowledge and confidence The programme offers video and audio resources, practical consultation examples and strategies for supporting individuals. Professor Ian Maidment at Aston Pharmacy School has been involved in a project with the Centre for Pharmacy Postgraduate Education (CPPE) to develop a new e-learning programme for community pharmacists, called Supporting people living with long COVID. The programme is designed to help community pharmacy teams build their skills, knowledge and confidence to support people managing the long-term effects of COVID-19. It was developed with researchers undertaking the National Institute for Health and Care Research (NIHR)-funded PHARM-LC research study: What role can community PHARMacy play in the support of people with long COVID? During the development of the e-learning resource, as well as with Professor Maidment, CPPE worked in collaboration with researchers from Keele University, the University of Kent, Midlands Partnership University NHS Foundation Trust and lechyd Cyhoeddus Cymru (Public Health Wales). The research draws on lived experience of long COVID, as well as the views of community pharmacy teams on what learning they need to better support people living with the condition. This new programme offers video and audio resources, practical consultation examples and strategies for supporting individuals through lifestyle advice, person-centred care and access to wider services. Professor Maidment said: “As an ex-community pharmacist, community pharmacy can have a key role in helping people living with long COVID. The approach is in line with the NHS 10 Year Health Plan, which aims to develop the role of community pharmacy in supporting people with long-term conditions.” Professor Carolyn Chew-Graham, professor of general practice research at Keele University, said: “Two million people in the UK are living with long COVID, a condition people are still developing, which may not be readily recognised, because routine testing for acute infection has largely stopped. For many, the pharmacy is the first place they seek advice about persisting symptoms following viral infection. The pharmacy team, therefore, has the potential to play a really important role in supporting people with long COVID. This learning programme provides evidence-based information to develop the confidence of pharmacy staff in talking to people with long COVID. Developed with people living with long COVID, the programme’s key message is to believe and empathise with people about their symptoms.” Visit www.cppe.ac.uk/programmes/l/covid-e-01 to access the e-learning programme. This project is funded by the National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme (Grant Reference Number NIHR205384).

View all posts